Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00929084 · ClinicalTrials.gov registry record · NA
Survivor Stories: Impact on Cancer Patients' Quality of Life and Follow-up
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 228
- Enrollment target
NCT00929084 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 228 participants.
The verdict
NCT00929084, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 228 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate in a randomized controlled trail, an innovative cancer communication strategy to help African American breast cancer patients cope with a variety of challenges during and after treatment and to better adhere to recommended treatment guidelines and follow-up care.
Interventions
- OTHER The Survivor Stories Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2009-11 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00929084
The ClinicalTrials.gov registry entry for NCT00929084 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 228 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which The Survivor Stories Tablet is the first listed.
NCT00929084 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00929084 about?
NCT00929084 is a clinical study titled "Survivor Stories: Impact on Cancer Patients' Quality of Life and Follow-up". The purpose of this study is to evaluate in a randomized controlled trail, an innovative cancer communication strategy to help African American breast cancer patients cope with a variety of challenges during and after treatment and to better adhere to recommended treatment guidelines and follow-up c...
What is the current status of trial NCT00929084?
This trial is currently completed. It is a NA study. The enrollment target is 228 participants. The study started on 2009-11. Estimated completion is 2016-12.
What interventions are being tested in trial NCT00929084?
The interventions under investigation include: The Survivor Stories Tablet (OTHER).
Who is sponsoring clinical trial NCT00929084?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.